Ascendis Pharma's total assets for Q2 2026 were €2.29B, an increase of 13.95% from the previous quarter. MX:ASND1N total liabilities were €849.18M for the fiscal quarter, a -44.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.